A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Endometrial Cancer|Ovarian Cancer
Interventions: DRUG: arzoxifene
Sponsor: Eli Lilly and Company